Shkreli still faces an antitrust trial set to begin later this month for allegedly directing the price gouging operation. FTC Announces Settlement With Vyera Pharmaceuticals Vyera...
“Pharma bro” Martin Shkreli was accused of using anticompetitive tactics to maintain a monopoly on the lifesaving drug Daraprim. A lawsuit, filed by the Federal Trade...
The Bureau of Prisons said it is investigating the conduct of notorious former hedge fund manager Martin Shkreli. The announcement follows a report by the Wall...
